---
schema_version: "secwatch.filing_event.v1"
accession: "0001157523-22-001521"
form_type: "8-K"
ticker: "CVSA"
cik: "0000730464"
company_name: "Covista Inc."
filed_at: "2022-11-03T23:59:59+00:00"
generated_at: "2026-06-22T10:23:03.887979+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Adtalem Q1 revenue $354.6M (+22.7%); adjusted EPS $0.88 (+151%); margins expand

## Summary
- Revenue $354.6M up 22.7% YoY; diluted EPS $0.05 vs loss of $1.17; adjusted EPS $0.88 up 151.4%.
- Adjusted operating income $65.1M up 78.7%; adjusted EBITDA $82.1M up 62.6%; margin expanded to 23.1% from 17.5%.
- Gross debt reduced by $101M (11.7%) in Q1.
- Segment: Chamberlain revenue flat, enrollment -4%; Walden enrollment -9.2%; Medical/Vet enrollment +3.4%.
- Reaffirmed FY2023 guidance: revenue $1,380M-$1,450M, adjusted EPS $3.95-$4.20.

## SEC filing metadata
- accession: 0001157523-22-001521
- form_type: 8-K
- ticker: CVSA
- cik: 0000730464
- company_name: Covista Inc.
- filed_at: 2022-11-03T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/730464/000115752322001521/0001157523-22-001521-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/730464/000115752322001521/a52959534.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001157523-22-001521
- JSON: https://secwatch.observer/filing/0001157523-22-001521.json
- Plain text: https://secwatch.observer/filing/0001157523-22-001521.txt

## Key facts
- Earnings Releases
  Covista Inc. reported first quarter fiscal 2023 ended Sept. 30, 2022 results: revenue $354.6 million, net income $2.2 million, EPS $0.05. Guidance reaffirmed.
  - Period: first quarter fiscal 2023 ended Sept. 30, 2022
  - Revenue: $354.6 million
  - Net income: $2.2 million
  - EPS: $0.05
  - Guidance: reaffirmed
  - Result: reported results
  source text: healthcare professionals while driving superior student outcomes. ” Financial Highlights Selected financial data for the three months ended Sept. 30, 2022: ● Revenue of $354.6 million increased 22.7% compared with the prior year due to the timing of the acquisition of Walden ● Diluted earnings per share increased to $0.05 from a loss of $1.17 in the prior
  evidence_url: https://www.sec.gov/Archives/edgar/data/730464/000115752322001521/0001157523-22-001521-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.